Search Results - "Hurwitz, Craig A."

Availability and Use of Palliative Care and End-of-Life Services for Pediatric Oncology Patients by JOHNSTON, Donna L, NAGEL, Kim, FRIEDMAN, Debra L, MEZA, Jane L, HURWITZ, Craig A, FRIEBERT, Sarah

“…Palliative care prevents or relieves the symptoms caused by life-threatening medical conditions. Previous surveys have shown both underuse and lack of…”
Get full text

Favorable Outcome for Adolescents With Acute Lymphoblastic Leukemia Treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols by BARRY, Elly, DEANGELO, Daniel J, SAMSON, Yvan, SCHORIN, Marshall, COHEN, Harvey J, SALLAN, Stephen E, SILVERMAN, Lewis B, NEUBERG, Donna, STEVENSON, Kristen, LOH, Mignon L, ASSELIN, Barbara L, BARR, Ronald D, CLAVELL, Luis A, HURWITZ, Craig A, MOGHRABI, Albert

“…Historically, adolescents with acute lymphoblastic leukemia (ALL) have had inferior outcomes when compared with younger children. We report the outcome of…”
Get full text

Final Results of a Prospective Clinical Trial With VAMP and Low-Dose Involved-Field Radiation for Children With Low-Risk Hodgkin's Disease by DONALDSON, Sarah S, LINK, Michael P, TARBELL, Nancy J, YOUNG, Jeffrey A, HUDSON, Melissa M, WEINSTEIN, Howard J, RAI, Shesh N, BRAIN, Sam, BILLETT, Amy L, HURWITZ, Craig A, KRASIN, Matthew, KUN, Larry E, MARCUS, Karen C

“…To evaluate outcome and assess complications in children and adolescents with low-risk Hodgkin's disease treated with vinblastine, doxorubicin, methotrexate,…”
Get full text

Safety and Efficacy of Gemtuzumab Ozogamicin in Combination With Chemotherapy for Pediatric Acute Myeloid Leukemia: A Report From The Children's Oncology Group by APLENC, Richard, ALONZO, Todd A, SIEVERS, Eric L, ARCECI, Robert J, GERBING, Robert B, LANGE, Beverly J, HURWITZ, Craig A, WELLS, Robert J, BERNSTEIN, Irwin, BUCKLEY, Patrick, KRIMMEL, Kathleen, SMITH, Franklin O

“…While gemtuzumab ozogamicin (GTMZ) is commonly used in the treatment of acute myeloid leukemia (AML) in combination with standard chemotherapy agents, the…”
Get full text

Use of [18F]Fluorodeoxyglucose Positron Emission Tomography in Evaluating Locally Recurrent and Metastatic Adrenocortical Carcinoma by Mackie, Gavin C., Shulkin, Barry L., Ribeiro, Raul C., Worden, Francis P., Gauger, Paul G., Mody, Rajen J., Connolly, Len P., Kunter, Ghada, Rodriguez-Galindo, Carlos, Wallis, Jerold W., Hurwitz, Craig A., Schteingart, David E.

“…Context: Adrenocortical carcinomas are uncommon, and their evaluation by [18F]fluorodeoxyglucose positron emission tomography (FDG PET) has not been well…”
Get full text

High Expression of the Very Late Antigen-4 Integrin Independently Predicts Reduced Risk of Relapse and Improved Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group by WALTER, Roland B, ALONZO, Todd A, LOKEN, Michael R, MESHINCHI, Soheil, GERBING, Robert B, HO, Phoenix A, SMITH, Franklin O, RAIMONDI, Susana C, HIRSCH, Betsy A, GAMIS, Alan S, FRANKLIN, Janet L, HURWITZ, Craig A

“…To evaluate the prognostic significance of the integrin cell adhesion molecule very late antigen-4 (VLA-4) in acute myeloid leukemia (AML). We prospectively…”
Get full text

Height and Weight in Children Treated for Acute Lymphoblastic Leukemia: Relationship to CNS Treatment by DALTON, Virginia Kimball, RUE, Montse, SCHORIN, Marshall, TARBELL, Nancy J, SALLAN, Stephen E, COHEN, Laurie E, SILVERMAN, Lewis B, GELBER, Richard D, ASSELIN, Barbara L, BARR, Ronald D, CLAVELL, Luis A, HURWITZ, Craig A, MOGHRABI, Albert, SAMSON, Yvan

“…We evaluated the long-term effects of treatment on height and weight in children with acute lymphoblastic leukemia (ALL) treated with one of the following…”
Get full text

Risk-Adapted, Combined-Modality Therapy With VAMP/COP and Response-Based, Involved-Field Radiation for Unfavorable Pediatric Hodgkin's Disease by HUDSON, Melissa M, KRASIN, Matthew, HOWARD, Scott, FRIEDMANN, Alison M, HURWITZ, Craig A, YOUNG, Jeffrey A, MARCUS, Karen C, RAI, Shesh, COWAN, Traci, WEINSTEIN, Howard J, LINK, Michael P, DONALDSON, Sarah S, BILLUPS, Catherine, MERCHANT, Thomas E, KUN, Larry, BILLET, Amy L, KASTE, Sue, TARBELL, Nancy J

“…To evaluate the efficacy of vinblastine, doxorubicin, methotrexate, and prednisone (VAMP) and cyclophosphamide, vincristine, and procarbazine (COP)…”
Get full text

VAMP and Low-Dose, Involved-Field Radiation for Children and Adolescents With Favorable, Early-Stage Hodgkin’s Disease: Results of a Prospective Clinical Trial by DONALDSON, Sarah S, HUDSON, Melissa M, WEINSTEIN, Howard J, LAMBORN, Kathleen R, LINK, Michael P, KUN, Larry, BILLETT, Amy Louise, MARCUS, Karen C, HURWITZ, Craig A, YOUNG, Jeffrey A, TARBELL, Nancy J

“…To evaluate outcome and assess toxicity of children and adolescents with early-stage, favorable Hodgkin's disease treated with vinblastine, doxorubicin,…”
Get full text

The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia by Lipshultz, Steven E, Rifai, Nader, Dalton, Virginia M, Levy, Donna E, Silverman, Lewis B, Lipsitz, Stuart R, Colan, Steven D, Asselin, Barbara L, Barr, Ronald D, Clavell, Luis A, Hurwitz, Craig A, Moghrabi, Albert, Samson, Yvan, Schorin, Marshall A, Gelber, Richard D, Sallan, Stephen E

“…Doxorubicin is an efficacious treatment for childhood acute lymphoblastic leukemia (ALL), but it is toxic to myocardial cells and can cause cardiomyopathy. In…”
Get full text

Parents as Teachers: Teaching Pediatrics Residents the Art of Engaging in Difficult Conversations by Wilson, Alexandra, Hurwitz, Craig A, Smith, Monica, Patino, Tracy, Kudalmana, Arya S, Gallas, Michelle

“…Physicians often lack the skills and confidence needed to have difficult conversations with patients and their families. Patients and families who have…”
Get full text

Caring for the Child With Cancer at the Close of Life: “There Are People Who Make It, and I'm Hoping I'm One of Them” by Hurwitz, Craig A, Duncan, Janet, Wolfe, Joanne

“…Approximately 25% of children with cancer die of their disease. Early in the course of a patient's illness, it is often impossible to determine whether the…”
Get full text

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01 by Silverman, Lewis B., Gelber, Richard D., Dalton, Virginia Kimball, Asselin, Barbara L., Barr, Ronald D., Clavell, Luis A., Hurwitz, Craig A., Moghrabi, Albert, Samson, Yvan, Schorin, Marshall A., Arkin, Steven, Declerck, Lieven, Cohen, Harvey J., Sallan, Stephen E.

“…The Dana-Farber Cancer Institute (DFCI) acute lymphoblastic leukemia (ALL) Consortium Protocol 91-01 was designed to improve the outcome of children with newly…”
Get full text

Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a Paediatric Oncology Group study by Chaleff, Stanley, Hurwitz, Craig A., Chang, Myron, Dahl, Gary, Alonzo, Todd A., Weinstein, Howard

“…Summary Relapse remains the leading cause of death in patients with acute myeloid leukaemia (AML). Relatively few new chemotherapy agents have been proven to…”
Get full text

Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG by Ho, Phoenix A., Kopecky, Kenneth J., Alonzo, Todd A., Gerbing, Robert B., Miller, Kristen L., Kuhn, Julia, Zeng, Rong, Ries, Rhonda E., Raimondi, Susana C., Hirsch, Betsy A., Oehler, Vivian, Hurwitz, Craig A., Franklin, Janet L., Gamis, Alan S., Petersdorf, Stephen H., Anderson, Jeanne E., Godwin, John E., Reaman, Gregory H., Willman, Cheryl L., Bernstein, Irwin D., Radich, Jerald P., Appelbaum, Frederick R., Stirewalt, Derek L., Meshinchi, Soheil

“…IDH1 SNP rs11554137 was recently reported in association with poor prognosis in normal karyotype adult acute myeloid leukemia (AML). We aimed to determine the…”
Get full text

Paclitaxel for the treatment of progressive or recurrent childhood brain tumors : A Pediatric Oncology phase II study by HURWITZ, Craig A, STRAUSS, Lewis C, KEPNER, James, KRETSCHMAR, Cynthia, HARRIS, Michael B, FRIEDMAN, Henry, KUN, Larry, KADOTA, Richard

“…To assess the efficacy and define the toxicity of paclitaxel given at a dosage of 350 mg/m2 every 3 weeks as a 24-hour continuous infusion to children with…”
Get full text

Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome by Pranzatelli, Michael R, Tate, Elizabeth D, Travelstead, Anna L, Barbosa, Jerry, Bergamini, Robert A, Civitello, Lucy, Franz, David N, Greffe, Brian S, Hanson, Robin D, Hurwitz, Craig A, Kalinyak, Karen A, Kelfer, Howard, Khakoo, Yasmin, Mantovani, John F, Nicholson, Stacy H, Sanders, Joann M, Wegner, Stephen

“…To determine if rituximab, an anti-CD20 monoclonal antibody, reduces cerebrospinal fluid (CSF) B-cell expansion in opsoclonus-myoclonus syndrome (OMS) and…”
Get full text

Doxorubicin Administration by Continuous Infusion Is Not Cardioprotective: The Dana-Farber 91-01 Acute Lymphoblastic Leukemia Protocol by Lipshultz, S. E.

Get full text

Adenocarcinoma of the cervix metastatic from a colon primary and diagnosed from a routine pap smear in a 17-year-old woman : A case report by SOZEN, Ibrahim, SMALL, Laurie, KOWALSKI, Mark, MAYO, Sara W, HURWITZ, Craig A

“…Carcinoma metastatic to the uterine cervix is very rare. The most frequent nongenital primary sites are the stomach and colon. A 17-year-old woman presented to…”
Get full text

Case 5-2002: A 15-Year-Old Boy with a Retro-orbital Mass and Impaired Vision by Hurwitz, Craig A, Faquin, William C

“…Presentation of Case A 15-year-old boy was admitted to the hospital because of a retro-orbital mass. The patient had been well until three weeks earlier, when…”
Get full text